Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,006 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00075478

Conditions
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
Locations
  • OHSU Cancer Institute-Southern Region Medford, Oregon, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details
Completed

Frontline Therapy in de Novo Multiple Myeloma Patients Under 65

NCT01206205

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Centre François Baclesse Caen, France
  • University Hospital of Dijon, Hôpital des Enfants Dijon, France
  • University Hospital of Grenoble, Hôpital A.Michallon, BP 217 X Grenoble, France
  • University Hospital Of Lille, Hôpital Claude Huriez Lille, France
View Trial Details
Completed

Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT)

NCT00642395

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Service of Blood Deseases - South Hospital Amiens, France
  • Service of Clinical Hematology - Bocage Hospital Angers, France
  • Service of Clinical Hematology - Cote Basque Hospital Bayonne, France
  • Service of Clinical Hematology - Minjoz Hospital Besançon, France
View all 34 locations
View Trial Details
Completed

Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy

NCT01056276

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Los Robles Hospital and Medical Center Thousand Oaks, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
View all 13 locations
View Trial Details
Completed

A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma

NCT02072863

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Department of Clinical Therapeutics, University of Athens Athens, Attica, Greece
  • Ospedale Oncologico Regionale Rionero in Vulture, Potenza, Italy
  • Azienda Ospedaliera Universitaria S Martino Genova, Italy
  • AOU Maggiore della Carita, SCDU Heamatology Novara, Italy
View Trial Details

Related conditions